PubMed HealthSearch

PubMed · 7021889

Does intermittent mandatory ventilation accelerate weaning?

Abstract

Intermittent mandatory ventilation (IMV) was introduced to facilitate the weaning of patients from mechanical ventilation. The outcome of ventilator management in 116 patients who were treated in the first three months of 1975 was compared retrospectively with that of 135 patients who were treated in the first three months of 1976. All patients who were treated in 1975 received conventional (assisted or controlled) mechanical ventilation. In 1976, seventy-seven patients (57%) were treated with the use of IMV, and 58 (43%) were treated with the use of conventional mechanical ventilation. Sixty-five patients who were treated in 1976 with the use of IMV were matched with patients who were treated in 1975 with the use of conventional ventilation, on the basis of age, sex, race, history of pulmonary disease, smoking history, diagnosis, service, and location of therapy. The average time spent on a ventilator by the IMV patients was 145 hours, whereas the matched control patients spent 142 hours. The length of hospitalization was 36 days for the IMV patients and 30 days for the control patients. These time periods were not significantly different and indicate that IMV did not reduce the length of ventilator management.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E N Schachter, D Tucker, G J Beck. 1981-09-11. Does intermittent mandatory ventilation accelerate weaning?. https://pubmed.ncbi.nlm.nih.gov/7021889/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.

Transplantation of hematopoietic stem cells from an HLA-compatible unrelated volunteer is an option for patients with acute leukemia lacking a family match. However, criteria for patient and donor selection and the most effective transplant procedures, including the number of hematopoietic cells, remain to be defined. We tested factors influencing outcome of 174 patients with primary acute leukemia receiving non-T-cell depleted marrow from unrelated donors. Median patient age was 20 years (range, 0.5 to 54 years). A multivariable analysis found that leukemia in remission at the time of transplantation was associated with improved leukemia-free survival (relative risk [RR] of treatment failure: 0.5, confidence interval [CI]: 0.3 to 0.7), and presence of blasts in the peripheral blood, as opposed to marrow involvement only or isolated extramedullary relapse, was associated with impaired outcome (RR of treatment failure: 2.5, CI: 1.7 to 5.0). The use of donors with a limited HLA-mismatch was associated with decreased leukemic relapse (RR: 0.5, CI: 0.3 to 0.9) but no improvement in leukemia-free survival compared with HLA-matched unrelated donors. Transplantation of a marrow cell dose above the median value of 3.65 x 10(8)/kg was associated with faster neutrophil (RR: 1.5, CI: 1.1 to 2.0) and platelet (RR: 4.5, CI: 2.7 to 7.5) engraftment, and decreased incidence of severe acute graft-versus-host disease (RR: 0.6, CI: 0.4 to 0.9). In patients transplanted in remission, the use of a marrow cell dose above the median translated into less nonleukemic death (RR: 0.2, CI: 0.1 to 0.4) and better leukemia-free survival (RR of treatment failure: 0.3, CI: 0.2 to 0.6). Transplant in remission with a high dose of marrow cells was associated with the best outcome in both children and adults.

Acute Disease

Acute myelitis associated with hyperIgEemia and atopic dermatitis.

We herein describe 4 adult patients with upper cervical myelitis presenting with paresthesia in the distal parts of all four limbs and who also all had hyperIgEemia. Two of them had full-blown atopic dermatitis at the time of neurologic illness, while the others had a preceding history of atopic dermatitis. All showed high signal intensity lesions at either the C3 or C4 segment, which mainly affected the posterior column on the T2-weighted spinal cord magnetic resonance imaging. All patients had specific IgE antibodies to two mite antigens and their onset of myelitis coincided with the seasonal increase of the mite antigens in Japan. Therefore, it is possible that the atopic conditions with hyperIgEemia in these patients may thus have contributed to the development of myelitis.

Acute Disease